🇺🇸 FDA
Patent

US 11110150

Complexes of IL-15 and IL-15Ralpha and uses thereof

granted A61KA61K2039/5152A61K2039/5156

Quick answer

US patent 11110150 (Complexes of IL-15 and IL-15Ralpha and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5152, A61K2039/5156, A61K2039/55527, A61K35/13